The Trans-Pacific Partnership (TPP) Agreement is intended to facilitate trade among 12 Asia-Pacific countries including the US, but its progress has been obstructed in part by ongoing controversy over provisions regarding intellectual property protections for pharmaceutical products. Some argue that if signed, the TPP will impact the availability or cost of essential medicines in low-income…
In September 2016, the Federal Judicial Center hosted a workshop for federal judges and law enforcement officials on issues relating to pretrial diversionary courts, exploring the question of “What Works and Why?” with a focus on our increasing understanding of the neuroscience behind trauma, mental health, and addiction, as well as evidence-based models of care…
Presentation Download the Presentation: “The Challenges of Conscience in a World of Compromise” About the Presenter Amy Sepinwall is Assistant Professor of Legal Studies and Business Ethics and James G. Campbell, Jr. Memorial Term Assistant Professor of Legal Studies and Business Ethics at the Wharton School at the University of Pennsylvania. Her research interests include individual and…
Presentation Download the Presentation: Pharmaceutical Federalism About the Presenter Patricia J. Zettler is associate professor of law at Georgia State University College of Law. She has expertise in the regulation of medicine, biotechnology and biomedical research, with an emphasis on the U.S. Food and Drug Administration. Her research focuses on the interaction between state and…
There is a growing push to incorporate patient voices more directly at the FDA in decision-making about investigational drugs, but what are the optimal parameters of patients’ contributions? To address these and other questions, we will consider two recent cases: flibanserin (the “female Viagra”) for hypoactive sexual desire disorder in women and eteplirsen for Duchenne…
At this event, faculty, colleagues, and students with shared interests in health law policy, biotechnology, and bioethics learned about what the Petrie-Flom Center does and how people can get involved. Faculty Director I. Glenn Cohen reviewed our sponsored research portfolio, introduced our staff and fellows, and described various opportunities for students and others. In addition,…
Far too many people across the country are left dead, injured, or traumatized by community violence. Communities can be safer when neuroscience, public health strategies, and collective advocacy are aligned in practice and policy. This event convened experts to discuss the best next steps to fostering a broad science-informed advocacy movement to effectively address community…
Our speakers will review and discuss the history of a technique called Facilitated Communication, purportedly used to communicate with individuals with severe autism, developmental delay, or brain injuries. The technique has since been comprehensively debunked — come and learn how providers can go wrong by failing to adhere to standards of evidence. Speakers Ways to…
This conference was the inaugural event of the Project on Advanced Care and Health Policy, a collaboration between the Coalition to Transform Advanced Care (C-TAC) and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. The event featured policymakers, thought leaders, family caregivers, clinicians, consumer advocates, and others working to…
Panelists will discuss the research being conducted at the Petrie-Flom Center as part of the Law and Ethics Initiative of the Football Players Health Study at Harvard University. Panelists The 39th Annual ASLME Health Law Professors Conference Hosted by the Boston University School of Law The American Society of Law, Medicine & Ethics Annual Health…
